Merck Animal Health Introduces Allflex® Link Reader to Connect Cattle Identification and Monitoring
November 17, 2026
Next-generation stick reader combines Allflex EID and SenseHub® monitoring reading capabilities to simplify data collection and create more connected cattle-management workflows
RAHWAY, N.J., Nov. 17, 2026 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the introduction of Allflex® Link, its next-generation stick reader designed to help cattle producers more seamlessly collect and connect individual animal identification and monitoring data.
Allflex Link combines radio frequency identification (RFID) capabilities for reading electronic identification (EID) tags with an integrated near-field communication (NFC) reader that enables pairing with SenseHub® monitoring solutions. Bringing these capabilities together in a single reader creates a link between an animal’s identity and monitoring information while helping simplify data collection and day-to-day workflows.
“Cattle producers are managing more information at the individual animal level, and they need technology that makes collecting and connecting that information easier,” said Travis Kellenberger, associate director of marketing, identification, at Merck Animal Health. “Allflex Link brings identification and monitoring capabilities together in one reader, helping producers simplify their workflows and giving them enhanced capabilities.”
Allflex Link builds on the current AWR300 stick reader as the next generation of Allflex RFID readers. Designed for livestock environments, Allflex Link features a lightweight, ergonomic design, a longer read range, 8 GB of memory and a large, backlit full-color display. Its sealed lithium-ion battery is designed for efficiency and durability, with more than 24 hours of battery life and 12 hours of dynamic reading. Allflex Link will be offered at the same price as the AWR300, providing producers with enhanced capabilities without an increase in price.
Allflex Link also integrates with Allflex Connect, the on-farm data collection app. Its ability to read both EID and NFC devices can help eliminate manual processes, simplify operations for farms using both technologies and support more efficient data collection. For producers currently using EID technology, the dual-reading capability also provides flexibility to incorporate SenseHub monitoring solutions without purchasing a separate reader.
“Allflex Link is about more than introducing a new reader,” added Kellenberger. “It’s another step toward making individual animal data easier to capture, connect and use across an operation. As identification and monitoring technologies continue to evolve, our goal is to give producers practical tools that work together and help them get more value from their data.”
For more information about Allflex Link, contact your Merck Animal Health representative or visit allflexusa.com.
Allflex® Link, the new stick reader from Merck Animal Health, combines Allflex EID tag reading with SenseHub® monitoring pairing to help cattle producers simplify data collection and connect animal identification and monitoring information.
About Merck Animal Health
Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is a global animal health business committed to The Science of Healthier Animals™. For more than 130 years, we have pioneered groundbreaking science. Today, we are driven by continuous innovation to develop breakthrough medicines, vaccines and technology. Rooted in direct experience on the farm and in the clinic, we work hand in hand with our customers every step of the way. Our singular focus is to empower those who care for animals, helping them manage their vital responsibility with confidence. Because when it comes to animal health, no one sees it like we do. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, X (formerly Twitter) and Instagram.
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
Media Contact
Kathleen Cuddy
(816) 301-8253
kathleen.cuddy@merck.com
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global